抗慢性乙型肝炎肝纤维化中成药研究进展  

Research Progress of Anti-chronic Hepatitis B Liver Fibrosis Chinese Patent Medicine

作　　者：帅苍南 张玉亭 刘敏[2] 耿嘉蔚[2] SHUAI Cang-nan;ZHANG Yu-ting;LIU Min;GENG Jia-wei(First Clinical Medical College,Yunnan University of Chinese Medicine,Kunming 650000,Yunnan,China;Department of Infectious Diseases and Liver Diseases,the First People's Hospital of Yunnan Province,Kunming 650000,Yunnan,China)

机构地区：[1]云南中医药大学第一临床医学院,云南昆明650000 [2]云南省第一人民医院感染性疾病及肝病科,云南昆明650000

出　　处：《医学信息》2022年第8期38-42,共5页Journal of Medical Information

摘　　要：肝纤维化指的是肝脏细胞外基质的弥漫性过度沉积和异常分布。在我国,慢性乙型肝炎是导致肝纤维化的主要原因。乙肝肝纤维化可进一步进展为肝硬化和肝癌。中医药在治疗乙肝及肝纤维化方面具有显著优势。本文就近年中医药抗肝纤维化的相关研究进行综述。Hepatic fibrosis refers to the diffuse excessive deposition and abnormal distribution of liver extracellular matrix.In China,chronic hepatitis B is the main cause of liver fibrosis.Hepatitis B liver fibrosis can further progress to cirrhosis and liver cancer.Traditional Chinese medicine has obvious advantages in the treatment of hepatitis B and liver fibrosis.This paper reviews the related research on anti-hepatic fibrosis of traditional Chinese medicine in recent years.

关 键 词：肝纤维化 乙型肝炎病毒 慢性乙型肝炎 中医药 

分 类 号：R256.4[医药卫生—中医内科学]